Nachrichten zur Eli Lilly & Co. Aktie

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) is issuing…

1 Incredible Reason to Buy LLYs Stock in November

Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.…

Eli Lilly stock tops $1,000 for the first time. Cramer says the next milestone is within reach

"People are beginning to realize maybe this thing is worth far more," CNBCs Jim Cramer says.…

Eli Lilly ist der bei GLP-1-Marktführer mit Erlösen von 125 Mrd. USD bis 2030. Warum die Aktie noch 50%iges Potenzial hat!

Der Kampf um die Krone bei GLP-1-Produkten tobt. Mit Eli Lilly zeichnet sich ein Gewinner ab. Eli Lilly untermauert seine…

Here are Wednesdays biggest analyst calls: Nvidia, Apple, Broadcom, Eli Lilly, AT&T, Carvana, Cava, Disney & more

Here are Wednesdays biggest calls on Wall Street.…

Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock?

Eli Lilly stock jumps 18% in a month as strong Q3 results, upgraded guidance and rising demand for Mounjaro and…

Eli Lilly cuts surprising deals with upstart biotech players

Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%,…

Leerink upgrades Eli Lilly following landmark deal with U.S. government

Leerink Partners sees shares of Eli Lilly adding another 19% from here.…

Here are Mondays biggest analyst calls: Nvidia, Tesla, Apple, Disney, Sunrun, Carmax, Eli Lilly, MP Materials & more

Here are Mondays biggest calls on Wall Street.…

3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 Drugs

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.…

Eli Lillys Breakout Is Here - Growing GLP-1 Market Share

…

Wall Street Week | Mamdani’s Win, Tariffs Fight, Pediatrics, Protein Boom

This week, can Congress delegate its authority over trade and tariffs to the president? The Supreme Court questioned the Trump…

Prediction: Eli Lilly Will Be Worth More Than Berkshire Hathaway by 2030

It could become the first trillion-dollar pharmaceutical company in the process.…

Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Heres What This Means for Investors.

Weight loss drugs generated about $10 billion for Lilly in the most recent quarter.…

Millions more Americans could access obesity drugs after Trumps deals with Eli Lilly, Novo Nordisk

Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur…

Eli Lilly, Novo Nordisks Historic GLP-1 Pricing Deals - What Investors Need To Know

…

Eli Lilly And Novo Nordisk: Historic GLP-1 Pricing Deals - What You Need To Know (NVO)

Novo Nordisk A/S & Eli Lilly and Company cut prices for top diabetes drugs, boosting accessibility and potential revenue. Click…

Hims & Hers falls after Novo, Lilly strike deal with White House for weight-loss drugs

** Shares of telehealth firm Hims & Hers NYSE:HIMS fall 1.1% to $41.1 premarket** U.S. President Donald Trump, Eli Lilly…

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

The deals are among the most politically significant announcements to date in the Trump administrations efforts to rein in high…

Heres how much weight loss drugs could cost you under Trumps deals with Eli Lilly, Novo Nordisk

The monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350, depending on the dosage…

TrumpRx GLP-1 pricing ‘less bad than feared’ for Hims & Hers, says Citi

Citi notes that the Trump administration announced that Eli Lilly (LLY) and Novo Nordisk (NVO) have agreed to significantly lower…

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study

The highest dose of Eli Lillys weekly injection helped patients with obesity or who are overweight lose 20.1% of their…

Novo, Lilly shares rise as Trump obesity drug deal nears

Shares of obesity drugmakers Eli Lilly and Novo Nordisk rose early on Thursday in anticipation of a White House deal…

Trump, Eli Lilly to announce weight loss drug price cut on Thursday, CBS reports

U.S. President Donald Trump on Thursday is expected to announce a deal with officials from Eli Lilly and Novo Nordisk…

Trump, Eli Lilly to announce weight loss drug price cut on Thursday, CBS reports By Reuters

Trump, Eli Lilly to announce weight loss drug price cut on Thursday, CBS reports…

Wall Street gets another reason to like Eli Lilly stock, and DuPonts spin is going to plan

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Lilly and Novo Nordisk near White House deal on obesity drug prices, Endpoints News reports

Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their weight…

Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies…

Is Eli Lilly a Millionaire Maker?

Eli Lilly has a leading position in a hot new drug category, but theres one notable problem to consider.…

Lilly Endowment sells $260m in Eli Lilly shares By Investing.com

Lilly Endowment sells $260m in Eli Lilly shares…

Tech rules Mondays stock market — plus, Eli Lillys big comeback and new vote of confidence

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Zweites Alzheimer-Medikament in Deutschland erhältlich

BERLIN (dpa-AFX) - Das Alzheimer-Medikament Donanemab (Handelsname Kisunla) ist ab sofort in Deutschland verfügbar. Nur wenige…

US-Pharmakonzern Eli Lilly plant Werk für 3 Milliarden Euro in den Niederlanden

INDIANAPOLIS/KATWIJK (dpa-AFX) - Der US-Pharmakonzern Lilly stockt seine Kapazitäten in Europa auf. Lilly plant den…

Lilly to build $3 billion Dutch plant to boost weight-loss pill production

Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand…

Notable healthcare headlines for the week: UNH, Eli Lilly and Merck in focus

…

Eli Lilly: The Price Upside Just Increased

…

Were raising our Eli Lilly price target — what a difference a quarter makes

The drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications…

Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar

The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a…

Stocks making the biggest moves premarket: Alphabet, Microsoft, Meta Platforms, Eli Lilly, Merck & more

These are some of the stocks posting the largest moves in early trading.…

Eli Lilly raises forecasts on surging demand for weight-loss drugs

Eli Lilly raised its full-year profit and revenue forecasts on Thursday as strong appetite for its widely popular weight-loss and…

Eli Lilly Q3 earnings and revenue top estimates, boosted by weight loss drug demand

Eli Lilly and Co (NYSE:LLY) on Thursday reported third quarter 2025 financial results that handily beat Wall Street forecasts, as the company…

Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound

Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailers locations or…

In Lilly vs Novo obesity drug battle, Trump price talks grab focus

As obesity drug heavyweights Eli Lilly and Novo Nordisk gear up to release results for the third quarter, investors are…

Eli Lilly bereitet Milliarden Dosen neuer Abnehmpille vor

Eli Lilly steht kurz vor einem der größten Produktstarts seiner Geschichte. Der Pharmakonzern aus Indianapolis hat bereits Milliarden Dosen seiner…

How Omvoh’s FDA Approval at Eli Lilly (LLY) Has Changed Its Investment Story

On October 27, 2025, Eli Lilly announced that the U.S. FDA approved a new, once-monthly single-injection maintenance regimen of Omvoh…

Eli Lilly is stockpiling its weight loss pill, plus Nvidia reveals (many) new partners

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development

Its the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten…

Lilly partners with Nvidia on AI supercomputer to speed up drug development

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and…

Down 15%, Should You Buy the Dip on Eli Lilly?

Lillys stock has pulled back from its 2024 highs, but that doesnt mean the shares are cheap enough to buy.…

Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings

Eli Lillys Q3 results hinge on strong demand for Mounjaro and Zepbound as investors weigh growth drivers against the pressure…